About Personal Genome
Personal Genome is a Healthcare company based in Baltimore (United States) founded in 2010, and was acquired by LabCorp in December 2021. Provider of advanced technology solutions for cancer genome analysis. Personal Genome has raised $327.45 million across 10 funding rounds from investors including LabCorp, Inova and TD Securities. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Diversified. Its legal entity is PERSONAL GENOME DIAGNOSTICS INC. Its competitors include Foundation Medicine, Personalis and Veritas Genetics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2010 and based in Baltimore, United States, Personal Genome operates in the biotechnology sector focused on oncology. Proprietary techniques have been developed to detect tumor mutations via analysis of circulating tumor DNA. CLIA certification is held for high-complexity molecular testing, encompassing whole exome sequencing, targeted panels, and plasma-based approaches to support clinical diagnostics.
- Headquarters Baltimore, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website personalgenome.com
- Social LinkedIn YouTube
- Acquired by LabCorp (Dec 2021)
- Legal Name Personal Genome Diagnostics Inc.
Apps and channels of Personal Genome
its YouTube channel Personal Genome Diagnostics (PGDx) has 43 subscribers.
Funding Insights of Personal Genome
Personal Genome has successfully raised a total of $327.45M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $103 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $327.45M
- Total Rounds 10
- Last Round Series C — $103M
- First Round $500,000
(Sep 2011)
- Investors Count 17
All 10 funding rounds of Personal Genome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $103M | Series C | – | Cowen | |
| May 2020 | $2.75M | Series B | – | – | – |
| Jun 2019 | $5M | Series B | – | – | – |
| Oct 2018 | $42M | Series B | – | Innovatus Capital Partners | – |
| Jan 2018 | $75M | Series B | – | – | |
| Dec 2017 | Series B | – | Camden Partners | – | |
| Oct 2017 | $75M | Series B | – | Bristol-Myers Squibb, New Enterprise Associates | |
| Nov 2015 | $21.4M | Series A | – | New Enterprise Associates | |
| Mar 2014 | $2.8M | Seed | – | – | – |
| Sep 2011 | $500,000 | Seed | – | – | – |
18 investors in total: 18 institutional.
Investors in Personal Genome
Personal Genome has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include LabCorp, Inova and TD Securities.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in medical technology are made by Vensana Capital. | vensanacap.com | Minneapolis, United States | ||
Early-stage and late-stage biotech and finance companies are funded. | rockspringscapital.com | Baltimore, United States | ||
Venture capital is provided to biomedical technology startups. | cataliocapital.com | New York, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Diversified debt funding is provided for growth capital opportunities. | innovatuscp.com | New York, United States | ||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Healthcare companies are invested in by this private equity firm. | pfmhealthsciences.com | San Francisco, United States | ||
Growth equity investments are made in lower middle market companies. | 1995 | camdenpartners.com | Owings Mills, United States | |
| cowincapital.com.cn | ||||
Early-stage investments are made in US companies across health sectors. | marylandventurefund.com | Columbia, United States |
Investor details for Personal Genome
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Personal Genome
16 people are tracked at Personal Genome (4 in leadership, 1 in board & advisors, 11 in team).
| Name | Role | Group |
|---|---|---|
Jennifer Dickey | VP, Regulatory & Quality | Leadership |
David Riley | Director, Bioinformatics | Leadership |
Christopher Hauck | VP, Commercial | Leadership |
Wei B. | Director of Software Quality | Leadership |
Jason Fuller | Director | Board & advisors |
Gunja Pathak | Regulatory Affairs Manager | Team |
Ryan Hanus | Regional Business Executive | Team |
Phillip D'Addio | Process Engineer | Team |
Paul McGregor | Manager/senior Scientist | Team |
Tom Kowalsky | Key Account Executive | Team |
Jesse Fox | Manager | Team |
Kenisha Williams | Data Analyst / Business Analyst | Team |
Ania W. | CLIA Quality Manager | Team |
Cesar Nalvarte | Team Manager | Team |
Christopher Greco | Software Engineer, Bioinformatics | Team |
Eugene Bowser | Design And Development Quality Manager | Team |
Complete people profiles for Personal Genome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Personal Genome
4 dated milestones of Personal Genome across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Personal Genome is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series C, of $103.0M.
- Exit Acquired by LabCorp.
Competitors of Personal Genome
Personal Genome has 3 listed competitors in our database, 3 of them funded. They include Foundation Medicine, Personalis and Veritas Genetics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. |
Detailed competitors of Personal Genome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Personal Genome
The website of Personal Genome (personalgenome.com) receives about 1.7K visits a month and ranks #6,619,311 among all websites worldwide, #6,665 in Biotechnology and Pharmaceuticals.
- Monthly visits1.7K
▼ 17.5% vs previous month
- Global rank#6,619,311
among all websites
- Category rank#6,665
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit2.3
- Average visit17 sec
- DevicesDesktop 53% · Mobile 47%
Websites whose visitors overlap most with Personal Genome. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
personalgenomes.org | personalgenomes.org | 100% | #14,523,702 | – | |
| genomedx.com | 83% | 3.6K | #4,872,000 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Personal Genome (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Personal Genome
Complete news archive for Personal Genome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Personal Genome
Personal Genome was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Personal Genome is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Personal Genome is a funded company, having raised a total of $327.45M across 10 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Sep 2011.
Founded in 2010 and based in Baltimore, United States, Personal Genome operates in the biotechnology sector focused on oncology. Proprietary techniques have been developed to detect tumor mutations via analysis of circulating tumor DNA. CLIA certification is held for high-complexity molecular testing, encompassing whole exome sequencing, targeted panels, and plasma-based approaches to support clinical diagnostics.
Personal Genome's top competitors include Foundation Medicine, Personalis and Veritas Genetics.
Personal Genome has 18 investors. Key investors include LabCorp, Inova, TD Securities, Bristol-Myers Squibb, and Vensana Capital.
Personal Genome operates through Personal Genome Diagnostics Inc..
Yes. Personal Genome was acquired by LabCorp in December 2021.